Skip to main content
Caplight Logo









Eclosion Ventures

Eclosion Ventures

Overview

Eclosion Ventures is a venture capital firm that manages the Eclosion life science investment fund, which focuses on translating cutting edge science into biotechnology companies developing transformational therapeutics and platform technologies.

Year Founded

2004

Portfolio Companies

1

Investments

Eclosion Ventures investments
CompanyDateStageLead
Netris PharmaDec 2020Series ACo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is Eclosion Ventures based?

Eclosion Ventures is headquartered in Geneva, Switzerland.

When was Eclosion Ventures founded?

Eclosion Ventures was founded in 2004.

How many portfolio companies does Eclosion Ventures have?

Eclosion Ventures has 1 portfolio company in Caplight's dataset.

What are some companies in Eclosion Ventures's portfolio?

Portfolio companies visible on Caplight include Netris Pharma.

What was Eclosion Ventures's most recent investment shown here?

Eclosion Ventures's most recent investment in this portfolio sample was in Netris Pharma in 2020.

What sectors does Eclosion Ventures focus on?

Eclosion Ventures focuses on Healthcare & Life Sciences.

What company stages does Eclosion Ventures focus on?

Eclosion Ventures typically invests at the Early stage.

Firmographic Details

HeadquartersGeneva
Year Founded2004

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?